rhEPO-Fc (Shanghai Meiye Biotechnology)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamerhEPO-Fc (Shanghai Meiye Biotechnology)
Drug Alias Namerecombinant human erythropoietin-Fc (anemia)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Meiye Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Meiye Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A